查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1762088

生物相似藥市場分析及預測（至 2034 年）：類型、產品、應用、最終用戶、技術、流程、組件、階段、服務、設備

Biosimilars Market Analysis and Forecast to 2034: Type, Product, Application, End User, Technology, Process, Component, Stage, Services, Device
出版日期: | 出版商: Global Insight Services | 英文 390 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

生物相似藥市場規模預計將從2024年的240億美元增加至2034年的1,177億美元，複合年成長率約為17.3%。生物相似生物製藥市場涵蓋與已核准的參考製劑高度相似，但在安全性和有效性方面無臨床意義差異的生物藥物。生技藥品專利到期推動了市場發展，這增加了對經濟高效且價格合理的醫療保健解決方案的需求。各地區的法規結構正在不斷發展，以支持生物相似藥的核准，鼓勵創新和競爭。隨著醫療保健系統尋求在成本壓力和對先進治療方案的需求之間取得平衡，生物相似藥市場預計將大幅成長。

行業概覽

生物相似藥市場正面臨全球關稅、地緣政治緊張局勢和不斷變化的供應鏈動態等複雜局面。日本和韓國正在策略性地加強其生物相似藥能力，利用創新來減輕關稅的影響並減少對外國生技藥品的依賴。中國正在國家支持下培育強大的國內生物相似藥產業，並越來越注重自力更生。台灣雖然在生物製藥製造業中舉足輕重，但在美國摩擦中面臨地緣政治脆弱性。在全球範圍內，由於生技藥品具有成本效益的替代品和人口老化，生物相似藥市場蓬勃發展。在彈性供應鏈和策略聯盟的推動下，預計到 2035 年市場將大幅擴張。中東衝突主要影響能源價格，但間接影響生物相似藥的生產成本和全球分銷物流。

市場區隔
類型 重組糖基化蛋白、重組非糖基化蛋白、多胜肽
產品 單株抗體、胰島素、紅血球生成素、顆粒細胞增生因子、人體生長荷爾蒙、干擾素、不孕激素
目的 癌症、慢性病、自體免疫疾病、血液疾病、感染疾病、生長激素缺乏症
最終用戶 醫院、診所、研究機構、製藥和生物技術公司
科技 重組DNA技術、單株抗體技術、蛋白質序列測定、生物資訊學
流程 上游工程、下游工序
成分 原料藥，最終製劑
步 臨床試驗、臨床前試驗和商業化
服務 契約製造、合約研究、醫藥諮詢
裝置 生物反應器、層析法系統

市場概況：

生物相似藥市場持續強勁擴張，主要原因是對具有成本效益的生物製藥的需求不斷成長以及原廠生技藥品專利到期。腫瘤學領域則受到癌症發生率上升和參考生技藥品高成本的驅動。腫瘤學生物學名藥對醫療保健提供者和付款人極具吸引力，因為它們可以顯著節省成本並具有相當的療效。此外，生物製藥開發和製造技術的進步正在推動生物相似藥的應用。自體免疫疾病和糖尿病等新興細分市場預計將出現顯著成長，這歸因於這些疾病的發病率上升以及醫生和患者對生物相似藥的接受度不斷提高。自體免疫疾病領域尤其有望受益於單株抗體的技術創新和下一代生物相似藥的開發，這些創新有望改善患者的治療效果並擴大治療選擇，從而顯著影響市場動態。

競爭概況：

生物相似藥市場以市場佔有率分佈的動態變化為特徵。由於癌症發病率的上升以及對經濟高效的替代療法的需求，腫瘤學領域成為當之無愧的領導者。由於自體免疫疾病的發病率上升以及對經濟實惠的替代療法的需求，免疫學領域緊隨其後。按地區分類，歐洲憑藉完善的法律規範和高滲透率保持市場主導地位；而亞太地區則在醫療支出成長和政府扶持措施的推動下，正經歷強勁成長。為了在這個快速成長的市場中佔據更大佔有率，產業主要企業正透過策略聯盟和產品發布積極強化其產品組合。生物相似藥市場的競爭格局在很大程度上受到監管因素的影響，尤其是在歐洲和北美等地區，這些地區嚴格的核准流程確保了產品的安全性和有效性。安進、山德士和輝瑞等公司處於領先地位，利用其強大的研發能力和策略聯盟來獲得競爭優勢。展望未來，隨著數款重磅生技藥品專利到期，以及生物相似藥日益受到醫療專業人士和患者的認可，生物相似藥市場預計將大幅成長。然而，智慧財產權糾紛和市場准入壁壘等挑戰依然存在。不過，生物技術的進步和持續的監管支持預計將為市場擴張帶來機會。

主要趨勢和促進因素：

隨著重磅生技藥品專利到期，生物相似藥市場迎來了強勁成長，競爭更加激烈。慢性病的盛行需要經濟有效的治療方案，這進一步推動了這個趨勢。各國政府和醫療機構正積極推廣生物相似藥的應用，以降低醫療成本。生物相似藥開發和生產領域的技術進步正在提高產品品質並縮短上市時間。這項進步對於獲得監管部門的核准和促進市場認可至關重要。此外，大型製藥公司不斷增加的研發投入正在刺激創新，從而催生出強大的生物相似藥產品線。製藥公司之間的合作與夥伴關係也在不斷增多，旨在利用專業知識並共用資源。這些趨勢正在加速生物相似藥的開發和商業化，擴大市場基礎。此外，醫療專業人員和患者對生物相似藥的認知度和接受度不斷提高也在推動市場需求。隨著生物相似藥變得越來越普遍，醫療保健基礎設施快速發展的新興市場充滿了成長機會，為產業參與者提供了巨大的成長潛力。

限制與挑戰：

生物相似藥市場面臨幾大限制和挑戰。主要挑戰是監管的複雜性和地區差異，這會導致核准延遲並增加成本。這種複雜性通常需要進行大量的臨床試驗，這增加了製造商的財務負擔。此外，醫生對開立生物相似藥的認知度和信任度嚴重不足，阻礙了其採用。包括專利訴訟在內的智慧財產權糾紛也是市場進入和擴張的障礙。此外，需要建立強大的藥物安全檢測系統來監測生物相似藥上市後的安全性和有效性，也帶來了物流和財務挑戰。最後，儘管生物相似藥具有成本優勢，但人們對原廠生物製劑的品牌忠誠度根深蒂固，使得其難以擴大市場佔有率。總之，這些因素阻礙了生物相似藥在醫療保健市場的快速成長和廣泛接受。

目錄

第1章生物相似藥市場概述

  • 研究目標
  • 生物相似藥市場定義和範圍
  • 報告限制
  • 調查年份和貨幣
  • 調查方法

第2章執行摘要

第3章重要考察

第4章生物相似藥市場展望

  • 生物相似藥市場細分
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 價值鏈分析
  • 4P模型
  • 安索夫矩陣

第5章：生物相似藥市場策略

  • 母市場分析
  • 供需分析
  • 消費者購買意向
  • 案例研究分析
  • 定價分析
  • 監管狀況
  • 供應鏈分析
  • 競爭產品分析
  • 近期動態

第6章：生物相似藥市場規模

  • 生物相似藥市場規模（以價值計算）
  • 生物相似藥市場規模（按數量計算）

第7章 生物相似藥市場（按類型）

  • 市場概覽
  • 重組糖基化蛋白
  • 重組非糖基化蛋白
  • 胜肽
  • 其他

第 8 章 生物相似藥市場（按產品）

  • 市場概覽
  • 單株抗體
  • 胰島素
  • 促紅血球生成素
  • 顆粒細胞增生因子
  • 人體生長荷爾蒙
  • 干擾素
  • 生育激素
  • 其他

第9章生物相似藥市場（按應用）

  • 市場概覽
  • 腫瘤學
  • 慢性病
  • 自體免疫疾病
  • 血液系統疾病
  • 感染疾病
  • 生長激素缺乏症
  • 其他

第 10 章 生物相似藥市場（按最終用戶）

  • 市場概覽
  • 醫院
  • 診所
  • 研究所
  • 製藥公司
  • 生技公司
  • 其他

第 11 章 生物相似藥市場（按技術）

  • 市場概覽
  • 重組DNA技術
  • 單株抗體技術
  • 蛋白質序列測定
  • 生物資訊學
  • 其他

第 12 章 生物相似藥市場（按製程）

  • 市場概覽
  • 上游工程
  • 下游工序
  • 其他

第 13 章。生物相似藥市場（按成分）

  • 市場概覽
  • 原料藥(API)
  • 成品配方
  • 其他

第 14 章生物相似藥市場分階段

  • 市場概覽
  • 臨床試驗
  • 臨床前試驗
  • 商業化
  • 其他

第15章 生物相似藥市場（依服務）

  • 市場概覽
  • 契約製造
  • 委託研究
  • 監理諮詢
  • 其他

第16章 生物相似藥市場（按設備）

  • 市場概覽
  • 生物反應器
  • 層析法系統
  • 其他

第17章 生物相似藥市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第18章競爭格局

  • 概述
  • 市場佔有率分析
  • 主要企業定位
  • 衝突領導地圖
  • 供應商基準化分析
  • 發展策略基準化分析

第19章 公司簡介

  • Alvotech
  • Coherus BioSciences
  • Amgen
  • Samsung Bioepis
  • Celltrion
  • Biocon
  • Sandoz
  • Mylan
  • Fresenius Kabi
  • Stada Arzneimittel
  • Dr Reddy's Laboratories
  • Lupin
  • Hikma Pharmaceuticals
  • Apotex
  • Teva Pharmaceutical Industries
  • Zydus Cadila
  • Torrent Pharmaceuticals
  • Cadila Healthcare
  • Alkem Laboratories
  • Gedeon Richter
簡介目錄
Product Code: GIS20363

Biosimilars Market is anticipated to expand from $24.0 billion in 2024 to $117.7 billion by 2034, growing at a CAGR of approximately 17.3%. Biosimilars Market encompasses biologic medical products highly similar to already approved reference products, offering no clinically meaningful differences in safety or efficacy. This market is driven by patent expirations of biologics, cost-effectiveness, and increasing demand for affordable healthcare solutions. Regulatory frameworks in various regions are evolving to support biosimilar approvals, fostering innovation and competition. The market is poised for significant growth as healthcare systems seek to balance cost pressures with the need for advanced therapeutic options.

Industry Overview:

The biosimilars market is navigating a complex landscape of global tariffs, geopolitical tensions, and evolving supply chain dynamics. Japan and South Korea are strategically enhancing their biosimilar capabilities, leveraging innovation to mitigate tariff impacts and reduce dependency on foreign biologics. China's focus on self-reliance is intensifying, with state-backed initiatives fostering a robust domestic biosimilars sector. Taiwan, while pivotal in biopharmaceutical manufacturing, faces geopolitical vulnerabilities amidst US-China frictions. Globally, the biosimilars market is buoyant, driven by cost-effective alternatives to biologics and an aging population. By 2035, the market is poised for significant expansion, contingent on resilient supply chains and strategic alliances. Middle East conflicts, while primarily affecting energy prices, indirectly influence biosimilar production costs and distribution logistics worldwide.

Market Segmentation
TypeRecombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Peptides
ProductMonoclonal Antibodies, Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor, Human Growth Hormone, Interferons, Fertility Hormones
ApplicationOncology, Chronic Diseases, Autoimmune Diseases, Blood Disorders, Infectious Diseases, Growth Hormone Deficiency
End UserHospitals, Clinics, Research Institutes, Pharmaceutical Companies, Biotechnology Firms
TechnologyRecombinant DNA Technology, Monoclonal Antibody Technology, Protein Sequencing, Bioinformatics
ProcessUpstream Processing, Downstream Processing
ComponentActive Pharmaceutical Ingredients (API), Finished Dosage Formulations
StageClinical Trials, Preclinical Studies, Commercialization
ServicesContract Manufacturing, Contract Research, Regulatory Consulting
DeviceBioreactors, Chromatography Systems

Market Overview:

The Biosimilars Market is experiencing robust expansion, primarily fueled by the rising need for cost-effective biologic therapies and the expiration of patents for original biologics. The oncology segment leads the market, driven by the increasing prevalence of cancer and the high cost of reference biologics. Biosimilars in oncology offer significant cost savings and comparable efficacy, making them highly attractive to healthcare providers and payers. Furthermore, advancements in biologic drug development and manufacturing technologies enhance their adoption. Emerging sub-segments, such as autoimmune diseases and diabetes, are poised for substantial growth due to the rising incidence of these conditions and the growing acceptance of biosimilars among physicians and patients. The autoimmune segment, in particular, is expected to benefit from ongoing innovations in monoclonal antibodies and the development of next-generation biosimilars, which promise improved patient outcomes and expanded therapeutic options, thereby significantly impacting market dynamics.

Geographical Overview:

The biosimilars market is witnessing remarkable growth, with regional dynamics playing a pivotal role. In North America, the market is expanding due to a robust regulatory framework and increasing healthcare expenditure. The United States, a key player, is driving growth through strategic collaborations and a focus on reducing healthcare costs. Europe stands as a leader in the biosimilars market, propelled by supportive government policies and a strong emphasis on cost-effective healthcare solutions. The region's well-established pharmaceutical industry and high acceptance rates among healthcare professionals further contribute to its dominance. Germany and the United Kingdom are at the forefront. In Asia Pacific, the biosimilars market is experiencing rapid expansion. This growth is driven by a surge in chronic diseases and an aging population. Countries like China and India are investing heavily in biosimilar development and manufacturing. Their large patient pools and increasing healthcare access further bolster market potential. Latin America is an emerging market for biosimilars, with growing awareness and acceptance among healthcare providers. Brazil and Mexico are leading the way, focusing on regulatory improvements and cost-saving initiatives. The region's potential is significant, given its evolving healthcare landscape. The Middle East & Africa region is gradually recognizing the benefits of biosimilars. The market here is driven by the need to improve healthcare affordability and accessibility. Countries like Saudi Arabia and South Africa are making strides in adopting biosimilars to enhance healthcare outcomes and economic efficiency.

Competition Overview:

The biosimilars market is characterized by a dynamic distribution of market share, with the oncology segment emerging as a prominent leader due to the increasing prevalence of cancer and the demand for cost-effective treatment alternatives. The immunology segment follows closely, driven by the rising incidence of autoimmune diseases and the subsequent need for affordable therapeutic options. Geographically, Europe maintains a leadership position in the market due to its well-established regulatory framework and high adoption rates, while the Asia-Pacific region is witnessing robust growth fueled by increasing healthcare expenditure and supportive government initiatives. Key industry players are actively enhancing their portfolios through strategic collaborations and product launches to capture a larger share of this burgeoning market. The competitive landscape of the biosimilars market is shaped significantly by regulatory influences, particularly in regions like Europe and North America, where stringent approval processes ensure product safety and efficacy. Companies such as Amgen, Sandoz, and Pfizer are at the forefront, leveraging their extensive research capabilities and strategic alliances to gain competitive advantage. Looking ahead, the market is poised for substantial growth, driven by the expiration of patents for several blockbuster biologics and the increasing acceptance of biosimilars among healthcare providers and patients. However, challenges such as intellectual property disputes and market entry barriers persist. Nonetheless, advancements in biotechnology and ongoing regulatory support are expected to create lucrative opportunities for market expansion.

Recent Developments:

The biosimilars market has experienced notable developments in recent months. Amgen announced a strategic partnership with a leading European pharmaceutical company to co-develop and commercialize a new biosimilar targeting autoimmune diseases, aiming to expand their presence in the European market. In regulatory news, the U.S. FDA approved a groundbreaking biosimilar for treating cancer, marking a significant milestone in oncology therapeutics and potentially reducing treatment costs. Pfizer and Biocon Biologics entered a joint venture to enhance their biosimilars portfolio, focusing on emerging markets in Asia and Africa, which are projected to see substantial growth in demand. Market analysts reported a surge in biosimilars adoption in the European Union, driven by favorable regulatory policies and increased physician acceptance, which is expected to boost market growth. Lastly, a prominent South Korean biosimilar manufacturer announced a major investment to expand its production facilities, aiming to meet the growing global demand for cost-effective biologic treatments. These developments underscore the dynamic nature of the biosimilars market, highlighting opportunities for growth and innovation.

Key Companies:

Alvotech, Coherus Bio Sciences, Amgen, Samsung Bioepis, Celltrion, Biocon, Sandoz, Mylan, Fresenius Kabi, Stada Arzneimittel, Dr Reddy's Laboratories, Lupin, Hikma Pharmaceuticals, Apotex, Teva Pharmaceutical Industries, Zydus Cadila, Torrent Pharmaceuticals, Cadila Healthcare, Alkem Laboratories, Gedeon Richter

Key Trends and Drivers:

The biosimilars market is experiencing robust growth, propelled by the expiration of patents for blockbuster biologics, which opens the market to biosimilar competition. This trend is further driven by the increasing prevalence of chronic diseases, which necessitates cost-effective treatment options. Governments and healthcare providers are actively promoting the adoption of biosimilars to reduce healthcare expenditure. Technological advancements in the development and manufacturing of biosimilars are enhancing product quality and reducing time-to-market. This progress is crucial in gaining regulatory approval and fostering market acceptance. Additionally, the growing investment in research and development by key pharmaceutical companies is fueling innovation, leading to a broader pipeline of biosimilar products. The market is also witnessing increased collaborations and partnerships among pharmaceutical companies to leverage expertise and share resources. This trend is accelerating the development and commercialization of biosimilars, thus expanding market reach. Moreover, the rising awareness and acceptance of biosimilars among healthcare professionals and patients are driving market demand. As biosimilars continue to gain traction, opportunities abound in emerging markets where healthcare infrastructure is rapidly evolving, presenting significant growth potential for industry players.

Restraints and Challenges:

The biosimilars market encounters several significant restraints and challenges. A primary challenge is the regulatory complexity and variability across regions, which can delay approvals and increase costs. This complexity often necessitates extensive clinical trials, adding to the financial burden on manufacturers. Furthermore, there is a notable lack of physician awareness and confidence in prescribing biosimilars, which hampers their adoption. Intellectual property disputes, including patent litigations, can also obstruct market entry and expansion. Additionally, the need for robust pharmacovigilance systems to monitor biosimilar safety and efficacy post-launch poses logistical and financial challenges. Lastly, the entrenched brand loyalty to original biologics makes it difficult for biosimilars to gain market share, despite their cost advantages. These factors collectively impede the swift growth and broader acceptance of biosimilars in the healthcare market.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Biosimilars Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Biosimilars Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Application
  • 2.6 Key Highlights of the Market, by End User
  • 2.7 Key Highlights of the Market, by Technology
  • 2.8 Key Highlights of the Market, by Process
  • 2.9 Key Highlights of the Market, by Component
  • 2.10 Key Highlights of the Market, by Stage
  • 2.11 Key Highlights of the Market, by Services
  • 2.12 Key Highlights of the Market, by Device
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Application
  • 3.5 Market Attractiveness Analysis, by End User
  • 3.6 Market Attractiveness Analysis, by Technology
  • 3.7 Market Attractiveness Analysis, by Process
  • 3.8 Market Attractiveness Analysis, by Component
  • 3.9 Market Attractiveness Analysis, by Stage
  • 3.10 Market Attractiveness Analysis, by Services
  • 3.11 Market Attractiveness Analysis, by Device
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Biosimilars Market Outlook

  • 4.1 Biosimilars Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Biosimilars Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Biosimilars Market Size

  • 6.1 Biosimilars Market Size, by Value
  • 6.2 Biosimilars Market Size, by Volume

7: Biosimilars Market, by Type

  • 7.1 Market Overview
  • 7.2 Recombinant Glycosylated Proteins
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Recombinant Non-Glycosylated Proteins
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Peptides
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Others
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region

8: Biosimilars Market, by Product

  • 8.1 Market Overview
  • 8.2 Monoclonal Antibodies
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Insulin
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Erythropoietin
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Granulocyte Colony-Stimulating Factor
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Human Growth Hormone
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Interferons
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Fertility Hormones
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Others
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region

9: Biosimilars Market, by Application

  • 9.1 Market Overview
  • 9.2 Oncology
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Chronic Diseases
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Autoimmune Diseases
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Blood Disorders
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Infectious Diseases
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Growth Hormone Deficiency
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Others
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region

10: Biosimilars Market, by End User

  • 10.1 Market Overview
  • 10.2 Hospitals
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Clinics
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Research Institutes
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Pharmaceutical Companies
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Biotechnology Firms
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Others
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region

11: Biosimilars Market, by Technology

  • 11.1 Market Overview
  • 11.2 Recombinant DNA Technology
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Monoclonal Antibody Technology
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Protein Sequencing
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Bioinformatics
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: Biosimilars Market, by Process

  • 12.1 Market Overview
  • 12.2 Upstream Processing
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Downstream Processing
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Others
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region

13: Biosimilars Market, by Component

  • 13.1 Market Overview
  • 13.2 Active Pharmaceutical Ingredients (API)
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Finished Dosage Formulations
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Biosimilars Market, by Stage

  • 14.1 Market Overview
  • 14.2 Clinical Trials
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Preclinical Studies
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Commercialization
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Biosimilars Market, by Services

  • 15.1 Market Overview
  • 15.2 Contract Manufacturing
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Contract Research
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Regulatory Consulting
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Biosimilars Market, by Device

  • 16.1 Market Overview
  • 16.2 Bioreactors
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Chromatography Systems
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Others
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region

17: Biosimilars Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Application
    • 17.2.5 North America Market Size and Forecast, by End User
    • 17.2.6 North America Market Size and Forecast, by Technology
    • 17.2.7 North America Market Size and Forecast, by Process
    • 17.2.8 North America Market Size and Forecast, by Component
    • 17.2.9 North America Market Size and Forecast, by Stage
    • 17.2.10 North America Market Size and Forecast, by Services
    • 17.2.11 North America Market Size and Forecast, by Device
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Application
      • 17.2.9.4 United States Market Size and Forecast, by End User
      • 17.2.9.5 United States Market Size and Forecast, by Technology
      • 17.2.9.6 United States Market Size and Forecast, by Process
      • 17.2.9.7 United States Market Size and Forecast, by Component
      • 17.2.9.8 United States Market Size and Forecast, by Stage
      • 17.2.9.9 United States Market Size and Forecast, by Services
      • 17.2.9.10 United States Market Size and Forecast, by Device
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Application
      • 17.2.10.4 Canada Market Size and Forecast, by End User
      • 17.2.10.5 Canada Market Size and Forecast, by Technology
      • 17.2.10.6 Canada Market Size and Forecast, by Process
      • 17.2.10.7 Canada Market Size and Forecast, by Component
      • 17.2.10.8 Canada Market Size and Forecast, by Stage
      • 17.2.10.9 Canada Market Size and Forecast, by Services
      • 17.2.10.10 Canada Market Size and Forecast, by Device
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Application
    • 17.3.5 Europe Market Size and Forecast, by End User
    • 17.3.6 Europe Market Size and Forecast, by Technology
    • 17.3.7 Europe Market Size and Forecast, by Process
    • 17.3.8 Europe Market Size and Forecast, by Component
    • 17.3.9 Europe Market Size and Forecast, by Stage
    • 17.3.10 Europe Market Size and Forecast, by Services
    • 17.3.11 Europe Market Size and Forecast, by Device
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.4 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Component
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Stage
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Device
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Application
      • 17.3.10.4 Germany Market Size and Forecast, by End User
      • 17.3.10.5 Germany Market Size and Forecast, by Technology
      • 17.3.10.6 Germany Market Size and Forecast, by Process
      • 17.3.10.7 Germany Market Size and Forecast, by Component
      • 17.3.10.8 Germany Market Size and Forecast, by Stage
      • 17.3.10.9 Germany Market Size and Forecast, by Services
      • 17.3.10.10 Germany Market Size and Forecast, by Device
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Application
      • 17.3.11.4 France Market Size and Forecast, by End User
      • 17.3.11.5 France Market Size and Forecast, by Technology
      • 17.3.11.6 France Market Size and Forecast, by Process
      • 17.3.11.7 France Market Size and Forecast, by Component
      • 17.3.11.8 France Market Size and Forecast, by Stage
      • 17.3.11.9 France Market Size and Forecast, by Services
      • 17.3.11.10 France Market Size and Forecast, by Device
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Application
      • 17.3.12.4 Spain Market Size and Forecast, by End User
      • 17.3.12.5 Spain Market Size and Forecast, by Technology
      • 17.3.12.6 Spain Market Size and Forecast, by Process
      • 17.3.12.7 Spain Market Size and Forecast, by Component
      • 17.3.12.8 Spain Market Size and Forecast, by Stage
      • 17.3.12.9 Spain Market Size and Forecast, by Services
      • 17.3.12.10 Spain Market Size and Forecast, by Device
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Application
      • 17.3.13.4 Italy Market Size and Forecast, by End User
      • 17.3.13.5 Italy Market Size and Forecast, by Technology
      • 17.3.13.6 Italy Market Size and Forecast, by Process
      • 17.3.13.7 Italy Market Size and Forecast, by Component
      • 17.3.13.8 Italy Market Size and Forecast, by Stage
      • 17.3.13.9 Italy Market Size and Forecast, by Services
      • 17.3.13.10 Italy Market Size and Forecast, by Device
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Application
      • 17.3.14.4 Netherlands Market Size and Forecast, by End User
      • 17.3.14.5 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.6 Netherlands Market Size and Forecast, by Process
      • 17.3.14.7 Netherlands Market Size and Forecast, by Component
      • 17.3.14.8 Netherlands Market Size and Forecast, by Stage
      • 17.3.14.9 Netherlands Market Size and Forecast, by Services
      • 17.3.14.10 Netherlands Market Size and Forecast, by Device
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Application
      • 17.3.15.4 Sweden Market Size and Forecast, by End User
      • 17.3.15.5 Sweden Market Size and Forecast, by Technology
      • 17.3.15.6 Sweden Market Size and Forecast, by Process
      • 17.3.15.7 Sweden Market Size and Forecast, by Component
      • 17.3.15.8 Sweden Market Size and Forecast, by Stage
      • 17.3.15.9 Sweden Market Size and Forecast, by Services
      • 17.3.15.10 Sweden Market Size and Forecast, by Device
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Application
      • 17.3.16.4 Switzerland Market Size and Forecast, by End User
      • 17.3.16.5 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.6 Switzerland Market Size and Forecast, by Process
      • 17.3.16.7 Switzerland Market Size and Forecast, by Component
      • 17.3.16.8 Switzerland Market Size and Forecast, by Stage
      • 17.3.16.9 Switzerland Market Size and Forecast, by Services
      • 17.3.16.10 Switzerland Market Size and Forecast, by Device
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Application
      • 17.3.17.4 Denmark Market Size and Forecast, by End User
      • 17.3.17.5 Denmark Market Size and Forecast, by Technology
      • 17.3.17.6 Denmark Market Size and Forecast, by Process
      • 17.3.17.7 Denmark Market Size and Forecast, by Component
      • 17.3.17.8 Denmark Market Size and Forecast, by Stage
      • 17.3.17.9 Denmark Market Size and Forecast, by Services
      • 17.3.17.10 Denmark Market Size and Forecast, by Device
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Application
      • 17.3.18.4 Finland Market Size and Forecast, by End User
      • 17.3.18.5 Finland Market Size and Forecast, by Technology
      • 17.3.18.6 Finland Market Size and Forecast, by Process
      • 17.3.18.7 Finland Market Size and Forecast, by Component
      • 17.3.18.8 Finland Market Size and Forecast, by Stage
      • 17.3.18.9 Finland Market Size and Forecast, by Services
      • 17.3.18.10 Finland Market Size and Forecast, by Device
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Application
      • 17.3.19.4 Russia Market Size and Forecast, by End User
      • 17.3.19.5 Russia Market Size and Forecast, by Technology
      • 17.3.19.6 Russia Market Size and Forecast, by Process
      • 17.3.19.7 Russia Market Size and Forecast, by Component
      • 17.3.19.8 Russia Market Size and Forecast, by Stage
      • 17.3.19.9 Russia Market Size and Forecast, by Services
      • 17.3.19.10 Russia Market Size and Forecast, by Device
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Component
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Stage
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Device
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.5 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Component
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Stage
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Device
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Application
      • 17.4.9.4 China Market Size and Forecast, by End User
      • 17.4.9.5 China Market Size and Forecast, by Technology
      • 17.4.9.6 China Market Size and Forecast, by Process
      • 17.4.9.7 China Market Size and Forecast, by Component
      • 17.4.9.8 China Market Size and Forecast, by Stage
      • 17.4.9.9 China Market Size and Forecast, by Services
      • 17.4.9.10 China Market Size and Forecast, by Device
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Application
      • 17.4.10.4 India Market Size and Forecast, by End User
      • 17.4.10.5 India Market Size and Forecast, by Technology
      • 17.4.10.6 India Market Size and Forecast, by Process
      • 17.4.10.7 India Market Size and Forecast, by Component
      • 17.4.10.8 India Market Size and Forecast, by Stage
      • 17.4.10.9 India Market Size and Forecast, by Services
      • 17.4.10.10 India Market Size and Forecast, by Device
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Application
      • 17.4.11.4 Japan Market Size and Forecast, by End User
      • 17.4.11.5 Japan Market Size and Forecast, by Technology
      • 17.4.11.6 Japan Market Size and Forecast, by Process
      • 17.4.11.7 Japan Market Size and Forecast, by Component
      • 17.4.11.8 Japan Market Size and Forecast, by Stage
      • 17.4.11.9 Japan Market Size and Forecast, by Services
      • 17.4.11.10 Japan Market Size and Forecast, by Device
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Application
      • 17.4.12.4 South Korea Market Size and Forecast, by End User
      • 17.4.12.5 South Korea Market Size and Forecast, by Technology
      • 17.4.12.6 South Korea Market Size and Forecast, by Process
      • 17.4.12.7 South Korea Market Size and Forecast, by Component
      • 17.4.12.8 South Korea Market Size and Forecast, by Stage
      • 17.4.12.9 South Korea Market Size and Forecast, by Services
      • 17.4.12.10 South Korea Market Size and Forecast, by Device
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Application
      • 17.4.13.4 Australia Market Size and Forecast, by End User
      • 17.4.13.5 Australia Market Size and Forecast, by Technology
      • 17.4.13.6 Australia Market Size and Forecast, by Process
      • 17.4.13.7 Australia Market Size and Forecast, by Component
      • 17.4.13.8 Australia Market Size and Forecast, by Stage
      • 17.4.13.9 Australia Market Size and Forecast, by Services
      • 17.4.13.10 Australia Market Size and Forecast, by Device
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Application
      • 17.4.14.4 Singapore Market Size and Forecast, by End User
      • 17.4.14.5 Singapore Market Size and Forecast, by Technology
      • 17.4.14.6 Singapore Market Size and Forecast, by Process
      • 17.4.14.7 Singapore Market Size and Forecast, by Component
      • 17.4.14.8 Singapore Market Size and Forecast, by Stage
      • 17.4.14.9 Singapore Market Size and Forecast, by Services
      • 17.4.14.10 Singapore Market Size and Forecast, by Device
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Application
      • 17.4.15.4 Indonesia Market Size and Forecast, by End User
      • 17.4.15.5 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.6 Indonesia Market Size and Forecast, by Process
      • 17.4.15.7 Indonesia Market Size and Forecast, by Component
      • 17.4.15.8 Indonesia Market Size and Forecast, by Stage
      • 17.4.15.9 Indonesia Market Size and Forecast, by Services
      • 17.4.15.10 Indonesia Market Size and Forecast, by Device
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Application
      • 17.4.16.4 Taiwan Market Size and Forecast, by End User
      • 17.4.16.5 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.6 Taiwan Market Size and Forecast, by Process
      • 17.4.16.7 Taiwan Market Size and Forecast, by Component
      • 17.4.16.8 Taiwan Market Size and Forecast, by Stage
      • 17.4.16.9 Taiwan Market Size and Forecast, by Services
      • 17.4.16.10 Taiwan Market Size and Forecast, by Device
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Application
      • 17.4.17.4 Malaysia Market Size and Forecast, by End User
      • 17.4.17.5 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.6 Malaysia Market Size and Forecast, by Process
      • 17.4.17.7 Malaysia Market Size and Forecast, by Component
      • 17.4.17.8 Malaysia Market Size and Forecast, by Stage
      • 17.4.17.9 Malaysia Market Size and Forecast, by Services
      • 17.4.17.10 Malaysia Market Size and Forecast, by Device
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Application
    • 17.5.5 Latin America Market Size and Forecast, by End User
    • 17.5.6 Latin America Market Size and Forecast, by Technology
    • 17.5.7 Latin America Market Size and Forecast, by Process
    • 17.5.8 Latin America Market Size and Forecast, by Component
    • 17.5.9 Latin America Market Size and Forecast, by Stage
    • 17.5.10 Latin America Market Size and Forecast, by Services
    • 17.5.11 Latin America Market Size and Forecast, by Device
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Application
      • 17.5.9.4 Brazil Market Size and Forecast, by End User
      • 17.5.9.5 Brazil Market Size and Forecast, by Technology
      • 17.5.9.6 Brazil Market Size and Forecast, by Process
      • 17.5.9.7 Brazil Market Size and Forecast, by Component
      • 17.5.9.8 Brazil Market Size and Forecast, by Stage
      • 17.5.9.9 Brazil Market Size and Forecast, by Services
      • 17.5.9.10 Brazil Market Size and Forecast, by Device
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Application
      • 17.5.10.4 Mexico Market Size and Forecast, by End User
      • 17.5.10.5 Mexico Market Size and Forecast, by Technology
      • 17.5.10.6 Mexico Market Size and Forecast, by Process
      • 17.5.10.7 Mexico Market Size and Forecast, by Component
      • 17.5.10.8 Mexico Market Size and Forecast, by Stage
      • 17.5.10.9 Mexico Market Size and Forecast, by Services
      • 17.5.10.10 Mexico Market Size and Forecast, by Device
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Application
      • 17.5.11.4 Argentina Market Size and Forecast, by End User
      • 17.5.11.5 Argentina Market Size and Forecast, by Technology
      • 17.5.11.6 Argentina Market Size and Forecast, by Process
      • 17.5.11.7 Argentina Market Size and Forecast, by Component
      • 17.5.11.8 Argentina Market Size and Forecast, by Stage
      • 17.5.11.9 Argentina Market Size and Forecast, by Services
      • 17.5.11.10 Argentina Market Size and Forecast, by Device
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Component
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Stage
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Device
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.5 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Component
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Stage
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Device
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Component
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Stage
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Device
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Application
      • 17.6.10.4 UAE Market Size and Forecast, by End User
      • 17.6.10.5 UAE Market Size and Forecast, by Technology
      • 17.6.10.6 UAE Market Size and Forecast, by Process
      • 17.6.10.7 UAE Market Size and Forecast, by Component
      • 17.6.10.8 UAE Market Size and Forecast, by Stage
      • 17.6.10.9 UAE Market Size and Forecast, by Services
      • 17.6.10.10 UAE Market Size and Forecast, by Device
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Application
      • 17.6.11.4 South Africa Market Size and Forecast, by End User
      • 17.6.11.5 South Africa Market Size and Forecast, by Technology
      • 17.6.11.6 South Africa Market Size and Forecast, by Process
      • 17.6.11.7 South Africa Market Size and Forecast, by Component
      • 17.6.11.8 South Africa Market Size and Forecast, by Stage
      • 17.6.11.9 South Africa Market Size and Forecast, by Services
      • 17.6.11.10 South Africa Market Size and Forecast, by Device
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Component
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Stage
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Device
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Alvotech
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Coherus BioSciences
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Amgen
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Samsung Bioepis
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Celltrion
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Biocon
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Sandoz
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Mylan
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Fresenius Kabi
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Stada Arzneimittel
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Dr Reddy's Laboratories
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Lupin
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Hikma Pharmaceuticals
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Apotex
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 Teva Pharmaceutical Industries
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 Zydus Cadila
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 Torrent Pharmaceuticals
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 Cadila Healthcare
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Alkem Laboratories
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 Gedeon Richter
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis